James G. Wong

Strathfield, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Correction: Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study.

Correction: Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study.

Journal: Ophthalmology and therapy

Published: May 13, 2026

Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study.

Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study.

Journal: Ophthalmology and therapy

Published: January 19, 2026

A combined ex vivo fundus imaging-histology protocol for clinicopathological validation of human donor eyes with limited medical history.

A combined ex vivo fundus imaging-histology protocol for clinicopathological validation of human donor eyes with limited medical history.

Journal: Scientific reports

Published: December 12, 2025

Lost to Follow-Up in Neovascular Age-Related Macular Degeneration: A Systematic Review of Global Trends, Risk Factors, and Clinical Consequences.

Lost to Follow-Up in Neovascular Age-Related Macular Degeneration: A Systematic Review of Global Trends, Risk Factors, and Clinical Consequences.

Journal: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde

Published: April 23, 2025

Response: Aflibercept for the treatment of pigmentary retinopathy in Kearns-Sayre Syndrome?

Response: Aflibercept for the treatment of pigmentary retinopathy in Kearns-Sayre Syndrome?

Journal: Documenta ophthalmologica. Advances in ophthalmology

Published: April 10, 2025

Anti-VEGF therapy for proliferative diabetic retinopathy in Kearns-Sayre syndrome.

Anti-VEGF therapy for proliferative diabetic retinopathy in Kearns-Sayre syndrome.

Journal: Documenta ophthalmologica. Advances in ophthalmology

Published: August 28, 2024

Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry.

Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry.

Journal: Clinical & experimental ophthalmology

Published: April 12, 2024

Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis.

Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis.

Journal: Clinical & experimental ophthalmology

Published: April 10, 2024

Long-term outcomes of anti-VEGF treatment of retinal vein occlusion.

Long-term outcomes of anti-VEGF treatment of retinal vein occlusion.

Journal: Eye (London, England)

Published: October 23, 2020

Long-term Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: The LATAR Study: Report 1: Ten-Year, Real-World Outcomes.

Long-term Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: The LATAR Study: Report 1: Ten-Year, Real-World Outcomes.

Journal: Ophthalmology. Retina

Published: May 27, 2020

Photodynamic therapy for polypoidal choroidal vasculopathy secondary to choroidal nevus.

Photodynamic therapy for polypoidal choroidal vasculopathy secondary to choroidal nevus.

Journal: International medical case reports journal

Published: March 01, 2017

Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab.

Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab.

Journal: Case reports in ophthalmology

Published: January 23, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026